Skip to content

Clinical trials

Completed Amyloidosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20053
20062
20071
20083
20093
20102
20113
20121
20138
20143
20154
20166
20173
20183
20198
20201
20213
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
Ionis Pharmaceuticals, Inc.6
Mayo Clinic5
Alnylam Pharmaceuticals4
The Cleveland Clinic4
Boston University3
Boston Medical Center2
Brigham and Women's Hospital2
National Cancer Institute (NCI)2
Prothena Biosciences Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis66
Immunoglobulin Light-chain Amyloidosis17
Amyloid Neuropathies, Familial14
Alzheimer Disease11
Cardiomyopathies8
Multiple Myeloma8
Amyloidosis, Familial5
Polyneuropathies5
Hematologic Neoplasms3
Leukemia3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.